FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955144879> ?p ?o ?g. }

• W2955144879 abstract "Objective: Type 2 diabetes (T2D) is more common in Hispanic than non-Hispanic white (NHW) populations worldwide, and ethnicity, among other factors, may affect response to therapy. The efficacy and safety of insulin glargine 100 units/mL (iGlar) and the fixed-ratio combination of iGlar and the glucagon-like peptide 1 receptor agonist lixisenatide (iGlarLixi) was assessed in Hispanic and NHW patients with T2D from 25 countries. Methods: In this post hoc analysis, data from two 30-week randomized controlled trials comparing iGlar and iGlarLixi in patients with T2D uncontrolled on basal insulin ± oral antidiabetes drugs (OADs; LixiLan-L: NCT02058160) or uncontrolled on metformin ± OADs (LixiLan-O: NCT02058147) were evaluated. Results: Of the 1,512 patients included across trials, 301 were Hispanic and 1,211 NHW. Compared with iGlar, iGlarLixi resulted in greater reductions in glycated hemoglobin (A1C) and 2-hour postprandial glucose and a higher proportion of patients at target A1C <7.0% (<53 mmol/mol), regardless of ethnicity. Among NHWs from the LixiLan-L trial, documented symptomatic hypoglycemia (plasma glucose ≤70 mg/dL) rates were higher with iGlar compared with iGlarLixi (P = .06), whereas this trend was reversed among Hispanics (P = .07). Nevertheless, in both trials, a greater proportion of patients taking iGlarLixi than iGlar reached the composite efficacy endpoints of target A1C without hypoglycemia and target A1C without weight gain, regardless of ethnicity. Conclusion: These results indicate that iGlarLixi is a viable therapeutic option for both Hispanic and NHW patients with T2D, as it is efficacious without a significant increase in hypoglycemia, irrespective of ethnicity. Abbreviations: A1C = glycated hemoglobin; BMI = body mass index; FPG = fasting plasma glucose; FRC = fixed-ratio combination; GLP-1 RA = glucagon-like peptide 1 receptor agonist; HDL-C = high-density-lipoprotein cholesterol; iGlar = insulin glargine; iGlarLixi = insulin glargine + lixisenatide; LDL-C = low-density-lipoprotein cholesterol; NHW = non-Hispanic white; OAD = oral antidiabetes drug; PPG = postprandial glucose; T2D = type 2 diabetes." @default.
• W2955144879 created "2019-07-12" @default.
• W2955144879 creator A5003615844 @default.
• W2955144879 creator A5047660894 @default.
• W2955144879 creator A5056956131 @default.
• W2955144879 creator A5061058170 @default.
• W2955144879 creator A5076844452 @default.
• W2955144879 creator A5084538612 @default.
• W2955144879 date "2019-11-01" @default.
• W2955144879 modified "2023-09-27" @default.
• W2955144879 title "Efficacy and Safety of Iglarlixi in Hispanics and Non-Hispanic Whites with Type 2 Diabetes" @default.
• W2955144879 cites W1613501644 @default.
• W2955144879 cites W2007221722 @default.
• W2955144879 cites W2049320250 @default.
• W2955144879 cites W2057287618 @default.
• W2955144879 cites W2075198558 @default.
• W2955144879 cites W2109728760 @default.
• W2955144879 cites W2144591407 @default.
• W2955144879 cites W2165250480 @default.
• W2955144879 cites W2226954704 @default.
• W2955144879 cites W2325443153 @default.
• W2955144879 cites W2376943461 @default.
• W2955144879 cites W2408691843 @default.
• W2955144879 cites W2514766623 @default.
• W2955144879 cites W2521422828 @default.
• W2955144879 cites W2591702989 @default.
• W2955144879 cites W2594451671 @default.
• W2955144879 cites W2653457112 @default.
• W2955144879 cites W2753932519 @default.
• W2955144879 cites W2775100391 @default.
• W2955144879 cites W2795700244 @default.
• W2955144879 cites W2894993577 @default.
• W2955144879 cites W2916996193 @default.
• W2955144879 doi "https://doi.org/10.4158/ep-2018-0615" @default.
• W2955144879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31241362" @default.
• W2955144879 hasPublicationYear "2019" @default.
• W2955144879 type Work @default.
• W2955144879 sameAs 2955144879 @default.
• W2955144879 citedByCount "0" @default.
• W2955144879 crossrefType "journal-article" @default.
• W2955144879 hasAuthorship W2955144879A5003615844 @default.
• W2955144879 hasAuthorship W2955144879A5047660894 @default.
• W2955144879 hasAuthorship W2955144879A5056956131 @default.
• W2955144879 hasAuthorship W2955144879A5061058170 @default.
• W2955144879 hasAuthorship W2955144879A5076844452 @default.
• W2955144879 hasAuthorship W2955144879A5084538612 @default.
• W2955144879 hasConcept C126322002 @default.
• W2955144879 hasConcept C134018914 @default.
• W2955144879 hasConcept C137403100 @default.
• W2955144879 hasConcept C144024400 @default.
• W2955144879 hasConcept C19165224 @default.
• W2955144879 hasConcept C2776442814 @default.
• W2955144879 hasConcept C2777180221 @default.
• W2955144879 hasConcept C2777538456 @default.
• W2955144879 hasConcept C2778199505 @default.
• W2955144879 hasConcept C2779306644 @default.
• W2955144879 hasConcept C2779920387 @default.
• W2955144879 hasConcept C2780323712 @default.
• W2955144879 hasConcept C2780668416 @default.
• W2955144879 hasConcept C2909524832 @default.
• W2955144879 hasConcept C555293320 @default.
• W2955144879 hasConcept C71924100 @default.
• W2955144879 hasConceptScore W2955144879C126322002 @default.
• W2955144879 hasConceptScore W2955144879C134018914 @default.
• W2955144879 hasConceptScore W2955144879C137403100 @default.
• W2955144879 hasConceptScore W2955144879C144024400 @default.
• W2955144879 hasConceptScore W2955144879C19165224 @default.
• W2955144879 hasConceptScore W2955144879C2776442814 @default.
• W2955144879 hasConceptScore W2955144879C2777180221 @default.
• W2955144879 hasConceptScore W2955144879C2777538456 @default.
• W2955144879 hasConceptScore W2955144879C2778199505 @default.
• W2955144879 hasConceptScore W2955144879C2779306644 @default.
• W2955144879 hasConceptScore W2955144879C2779920387 @default.
• W2955144879 hasConceptScore W2955144879C2780323712 @default.
• W2955144879 hasConceptScore W2955144879C2780668416 @default.
• W2955144879 hasConceptScore W2955144879C2909524832 @default.
• W2955144879 hasConceptScore W2955144879C555293320 @default.
• W2955144879 hasConceptScore W2955144879C71924100 @default.
• W2955144879 hasLocation W29551448791 @default.
• W2955144879 hasOpenAccess W2955144879 @default.
• W2955144879 hasPrimaryLocation W29551448791 @default.
• W2955144879 hasRelatedWork W1976067058 @default.
• W2955144879 hasRelatedWork W2038714538 @default.
• W2955144879 hasRelatedWork W2043231410 @default.
• W2955144879 hasRelatedWork W2062014697 @default.
• W2955144879 hasRelatedWork W2604162587 @default.
• W2955144879 hasRelatedWork W2606062157 @default.
• W2955144879 hasRelatedWork W2765703925 @default.
• W2955144879 hasRelatedWork W2809415248 @default.
• W2955144879 hasRelatedWork W2892632004 @default.
• W2955144879 hasRelatedWork W2907479789 @default.
• W2955144879 hasRelatedWork W2911886982 @default.
• W2955144879 hasRelatedWork W2946709917 @default.
• W2955144879 hasRelatedWork W2952077955 @default.
• W2955144879 hasRelatedWork W2996231878 @default.
• W2955144879 hasRelatedWork W2997228830 @default.
• W2955144879 hasRelatedWork W3007193360 @default.
• W2955144879 hasRelatedWork W3015614997 @default.
• W2955144879 hasRelatedWork W3038834756 @default.
• W2955144879 hasRelatedWork W3188644133 @default.

• next